Muscular dystrophy, Neuroscience 2013, mobile apps, knee ligaments and more in this week’s LabBook, our weekly roundup of University of Chicago Medicine & Biological Sciences research news from our blogs, around campus and the internet.
This week on the blog:
- Last weekend nearly 30,000 neuroscientists and neuroscientists-in-training made their way to the San Diego bay front for Neuroscience 2013. Check out our two-part coverage (Part 1, Part 2) of UChicago scientists at the conference, complete with video presentations.
- Last week UChicago physicians and entrepreneurs also gathered to discuss how mobile technology is changing health care.
- DNA is often called “the building block of life,” but life on earth may have started with its partner molecule, RNA.
- We spoke to orthopedic surgeon Martin Leland the discovery a new knee ligament and how it could affect those undergoing ACL surgery.
From our partner blog UChicago Cancer Conversations:
- Renowned UChicago cancer geneticist Janet D. Rowley, MD, has been named this year’s recipient of the Partners in Discovery Award from the University of Chicago Cancer Research Foundation (UCCRF) Women’s Board.
Research in the news:
- Today and tomorrow, the MacLean Center for Clinical Medical Ethics is celebrating its 25th Annual Dorothy J. MacLean Fellows Conference, marking a milestone for the program that pioneered the formal study of clinical medical ethics in the early 1980s.
- Speaking of ethics, Peter Angelos, associate director of the MacLean Center, went on WTTW’s Chicago Tonight to discuss ethical issues in the doctor-patient relationship.
- Medscape featured Richard Kraig’s research on a potential new therapy for multiple sclerosis that stimulates nerve cell regrowth. Science Life previously covered Kraig’s research on this area after the NIH awarded him a $1.5M grant in September.
- Finally, the Kurt+Peter Foundation, a non-profit that raises funds to apply current science to potential therapies for muscular dystrophy, awarded a two-year grant to Elizabeth McNally, professor of medicine and human genetics at the University of Chicago, to study a potential treatment for limb girdle muscular dystrophy, type 2C—a rare but severe form of muscular dystrophy.